9-132897550-G-T
Variant summary
Our verdict is Likely benign. The variant received -1 ACMG points: 2P and 3B. PM2BP4_ModerateBP6
The NM_000368.5(TSC1):c.2686C>A(p.Leu896Ile) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. L896F) has been classified as Uncertain significance.
Frequency
Consequence
NM_000368.5 missense
Scores
Clinical Significance
Conservation
Publications
- tuberous sclerosisInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- tuberous sclerosis 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, PanelApp Australia, Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae)
- lung lymphangioleiomyomatosisInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- tuberous sclerosis complexInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -1 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000368.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TSC1 | NM_000368.5 | MANE Select | c.2686C>A | p.Leu896Ile | missense | Exon 21 of 23 | NP_000359.1 | ||
| TSC1 | NM_001406592.1 | c.2686C>A | p.Leu896Ile | missense | Exon 21 of 23 | NP_001393521.1 | |||
| TSC1 | NM_001406593.1 | c.2686C>A | p.Leu896Ile | missense | Exon 21 of 23 | NP_001393522.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TSC1 | ENST00000298552.9 | TSL:1 MANE Select | c.2686C>A | p.Leu896Ile | missense | Exon 21 of 23 | ENSP00000298552.3 | ||
| TSC1 | ENST00000490179.4 | TSL:3 | c.2686C>A | p.Leu896Ile | missense | Exon 22 of 24 | ENSP00000495533.2 | ||
| TSC1 | ENST00000643875.1 | c.2686C>A | p.Leu896Ile | missense | Exon 21 of 23 | ENSP00000495158.1 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD2 exomes AF: 0.00000402 AC: 1AN: 248644 AF XY: 0.00 show subpopulations
GnomAD4 exome Cov.: 37
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Uncertain:2
The p.L896I variant (also known as c.2686C>A), located in coding exon 19 of the TSC1 gene, results from a C to A substitution at nucleotide position 2686. The leucine at codon 896 is replaced by isoleucine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
Tuberous sclerosis 1 Benign:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at